UK markets closed

Celularity Inc. (CELU)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
3.2900+0.2300 (+7.52%)
At close: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 71.67M
Enterprise value 132.47M
Trailing P/E 1.86
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)3.93
Price/book (mrq)2.37
Enterprise value/revenue 8.96
Enterprise value/EBITDA -0.78

Trading information

Stock price history

Beta (5Y monthly) 0.30
52-week change 3-32.03%
S&P500 52-week change 322.38%
52-week high 38.9000
52-week low 31.5900
50-day moving average 34.5219
200-day moving average 33.2715

Share statistics

Avg vol (3-month) 376.67k
Avg vol (10-day) 348.41k
Shares outstanding 521.78M
Implied shares outstanding 621.78M
Float 89.56M
% held by insiders 150.95%
% held by institutions 114.72%
Shares short (15 Apr 2024) 4393.14k
Short ratio (15 Apr 2024) 47.39
Short % of float (15 Apr 2024) 43.40%
Short % of shares outstanding (15 Apr 2024) 41.80%
Shares short (prior month 15 Mar 2024) 4388.27k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:10
Last split date 329 Feb 2024

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)30 Sept 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-430.51%

Management effectiveness

Return on assets (ttm)-20.48%
Return on equity (ttm)-186.55%

Income statement

Revenue (ttm)14.79M
Revenue per share (ttm)0.89
Quarterly revenue growth (yoy)-8.40%
Gross profit (ttm)N/A
EBITDA -87.91M
Net income avi to common (ttm)-181.41M
Diluted EPS (ttm)-10.3000
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)273k
Total cash per share (mrq)0.01
Total debt (mrq)61.08M
Total debt/equity (mrq)201.93%
Current ratio (mrq)0.19
Book value per share (mrq)1.56

Cash flow statement

Operating cash flow (ttm)-63.93M
Levered free cash flow (ttm)-15.24M